(Q44129113)

30 November 2017

1 reference

title

Increased dopamine turnover after partial loss of dopaminergic neurons: compensation or toxicity? (English)

1 reference

30 November 2017

0 references

Michael J Zigmond

1

1 reference

30 November 2017

Teresa G Hastings

series ordinal

2

1 reference

30 November 2017

Ruth G Perez

series ordinal

3

1 reference

30 November 2017

publication date

1 September 2002

1 reference

30 November 2017

number of pages

5

1 reference

Parkinsonism and Related Disorders

inferred from page(s)

published in

1 reference

30 November 2017

volume

8

1 reference

30 November 2017

issue

6

1 reference

30 November 2017

page(s)

389-393

1 reference

Chemical neuroanatomy of the basal ganglia--normal and in Parkinson's disease

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900019-6

7 January 2021

Etiology and pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900019-6

7 January 2021

Cytotoxic and genotoxic potential of dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900019-6

7 January 2021

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900019-6

7 January 2021

Programmed cell death: does it play a role in Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900019-6

7 January 2021

Cell death mechanisms in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900019-6

7 January 2021

Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-Hydroxydopamine

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900019-6

7 January 2021

Adipsia and Aphagia after 6-Hydroxydopamine Induced Degeneration of the Nigro-striatal Dopamine System

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900019-6

7 January 2021

6-hydroxy-dopamine induced degeneration of central monoamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900019-6

7 January 2021

Compensations after lesions of central dopaminergic neurons: some clinical and basic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900019-6

7 January 2021

Oxidative stress, mitochondrial respiration, and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900019-6

7 January 2021

Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900019-6

7 January 2021

Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900019-6

7 January 2021

Identification of catechol-protein conjugates in neostriatal slices incubated with [3H]dopamine: impact of ascorbic acid and glutathione

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900019-6

7 January 2021

A role for alpha-synuclein in the regulation of dopamine biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900019-6

7 January 2021

10.1016/S1353-8020(02)00019-6

Identifiers

DOI

1 reference

30 November 2017

1 reference